Skip to main content
. 2023 Jul 27;13:1204513. doi: 10.3389/fonc.2023.1204513

Figure 1.

Figure 1

The role of TME and CSCs in sorafenib resistance of HCC. Cancer stem cells could survive with the help of components of TME under the treatment of sorafenib, leading to drug resistance and tumor recurrence. TME, tumor microenvironment; CSCs, cancer stem cells; CAF, cancer-associated fibroblasts; ECM, extracellular matrix; HCC, hepatocellular carcinoma.